The latest market report published by Acute Market Reports “Global Smart Inhalers Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global smart inhalers market was valued at US$ 1,006.6 Mn in 2017, and is expected to reach US$ 3,674.6 Mn by 2026, expanding at a CAGR of 15.7% from 2018 to 2026.
According to the research findings of the World Health Organization (WHO), chronic obstructive pulmonary disease is responsible for 5% of global deaths annually. There is no permanent cure for chronic respiratory illnesses such as COPD, asthma, and bronchitis. Immediate symptomatic relief provided by respiratory inhalation is the best possible cure, hence smart inhalers possess impressive market growth in the near future due to excellent patient adherence and compliance to the treatment regimen.
Metered-dose inhalers (MDIs) are reigning the type segment for the smart inhalers market. Excellent PK/PD profile achieved during the drug delivery and increasing demand in geriatric patients suffering from chronic illness drive the metered dose inhalers market growth. Dry powder inhalers have gained tremendous attraction in recent times due to the drug irritation and severe adverse effects caused by the propellants employed in MDIs. Nebulizers are widely employed in pediatric patients due to the higher safety and efficacy associated with the drug delivery system.
Chronic obstructive pulmonary disease is currently leading the application segment for the smart inhalers market. Rampant growth of smokers in developed countries and rising industrialization in developing nation has led to the rise of air pollution and exposure to occupational dust and fumes. Asthma will be the fastest-growing market in the near future due to the rising prevalence of hereditary asthma in children and requires immediate symptomatic relief due to constriction of respiratory muscles.
In the present scenario, North America with a share of 38% is leading the regional segment for the smart inhalers market. The key features that contribute towards its supremacy is rampant growth in tobacco smokers and the domicile of major players such as Propeller Health, Cohero Health, 3M Healthcare, etc. Europe accounts for a 29% market share, on account of an increasing number of pediatric patients suffering from asthma and strategic collaboration between pharmaceutical giants and software companies to provide smart inhaler systems. The Asia Pacific with a market share of 20% will be the fastest-growing regional segment during the forecast period on account of increasing geriatric patients suffering from chronic pulmonary illness and the emergence of local players exerting stringent competition to western giants in smart inhalers market.
Browse the full report Smart Inhalers Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 at https://www.acutemarketreports.com/report/smart-inhalers-market
Companies in collaboration with pharmaceutical key players engaged in the development of smart inhalers are Amiko, Adherium Limited, Cohero Health, 3M Healthcare, Opko Health, Inc., Propeller Health, Philips Respironics, Sensirion AG, Teva Pharmaceutical Industries Limited, and Vectura Group, Plc.
Key Market Movements:
• Increasing number of geriatric patients suffering from chronic respiratory illness
• Significant increase in the number of tobacco smokers and rising air pollution
• Recent launch of innovative smart apps and wireless services to enhance drug delivery and patient compliance
The Global Smart Inhalers Market is Segmented into:
|Segmentation||By Type (2016–2026; US$ Mn)|
|By Application (2016–2026; US$ Mn)|
|Geography Segment (2016–2026; US$ Mn)|
*Complete segmentation list is on the report page
Key questions answered in this report
- What are the latest strategic collaboration and mergers taking place between IT healthcare providers and pharmaceutical giants providing respiratory inhalers?
- What are the DROs associated with this market?
- What is the global prevalence rate of COPD and how will It impact its treatment?
- What will be the factors responsible for the significant growth of dry powder inhalers in the near future?
- What are the primary features responsible for the supremacy of North America in this market?
Table of Contents
Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global SI Market Portraiture
2.2. Global SI Market, by Type, 2017 (US$ Mn)
2.3. Global SI Market, by Application, 2017 (US$ Mn)
2.4. Global SI Market, by Geography, 2017 (US$ Mn)
Chapter 3. Smart Inhalers (SI) Market: Dynamics and Future Outlook
3.1. Market Overview
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global SI Market, by Key Players, 2017
Chapter 4. Global Smart Inhalers (SI) Market, by Type
4.2. Metered Dose Inhalers
4.3. Dry Powder Inhalers
Chapter 5. Global Smart Inhalers (SI) Market, by Application
5.2. Chronic Obstructive Pulmonary Disease (COPD)
Chapter 6. Global Smart Inhalers (SI) Market, by Geography
6.2. North America SI Market Analysis, 2016 – 2026
6.2.1. North America SI Market, by Type, 2016 – 2026 (US$ Mn)
6.2.2. North America SI Market, by Application, 2016 – 2026 (US$ Mn)
6.2.3. North America SI Market, by Country, 2016 – 2026 (US$ Mn)
6.3. Europe SI Market Analysis, 2016 – 2026
6.3.1. Europe SI Market, by Type, 2016 – 2026 (US$ Mn)
6.3.2. Europe SI Market, by Application, 2016 – 2026 (US$ Mn)
6.3.3. Europe SI Market, by Country/Region, 2016 – 2026 (US$ Mn)
220.127.116.11. Rest of Europe
6.4. Asia Pacific SI Market Analysis, 2016 – 2026
6.4.1. Asia Pacific SI Market, by Type, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific SI Market, by Application, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific SI Market, by Country/Region, 2016 – 2026 (US$ Mn)
18.104.22.168. Rest of Asia Pacific
6.5. Latin America SI Market Analysis, 2016 – 2026
6.5.1. Latin America SI Market, by Type, 2016 – 2026 (US$ Mn)
6.5.2. Latin America SI Market, by Application, 2016 – 2026 (US$ Mn)
6.5.3. Latin America SI Market, by Country/Region, 2016 – 2026 (US$ Mn)
22.214.171.124. Rest of Latin America
6.6. Middle East and Africa SI Market Analysis, 2016 – 2026
6.6.1. MEA SI Market, by Type, 2016 – 2026 (US$ Mn)
6.6.2. MEA SI Market, by Application, 2016 – 2026 (US$ Mn)
6.6.3. MEA SI Market, by Country/Region, 2016 – 2026 (US$ Mn)
126.96.36.199. Rest of MEA
Chapter 7. Company Profiles
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Adherium Limited
7.3. Cohero Health
7.4. 3M Healthcare
7.5. Opko Health, Inc.
7.6. Propeller Health
7.7. Philips Respironics
7.8. Sensirion AG
7.9. Teva Pharmaceutical Industries Ltd.
7.10. Vectura Group, Plc.
Acute Market Reports is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives.
Acute Market Reports
Address: 90 Church St, FL 1 #3514,
New York, NY 10008 United States
Toll Free(US/CANADA): +1-855-455-8662